Skip to main content

Xenetic Biosciences Inc

For the period ended Mar 31, 2025. Filed May 13, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 13, 2025

XBIO$1.87+0.3%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

FORM 10-Q

QUARTERLY PERIOD ENDED MARCH 31, 2025

PART I · FINANCIAL INFORMATION
Item 1Condensed Consolidated Financial Statements:3
Condensed Consolidated Balance Sheets as of March 31, 2025 (Unaudited) and December 31, 20243
Condensed Consolidated Statements of Operations (Unaudited) for the three months ended March 31, 2025 and 20244
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) for the three months ended March 31, 2025 and 20245
Condensed Consolidated Statements of Cash Flows (Unaudited) for the three months ended March 31, 2025 and 20246
Notes to Condensed Consolidated Financial Statements (Unaudited)7
Item 2Management’s Discussion and Analysis of Financial Condition and Results of Operations13
Item 3Quantitative and Qualitative Disclosures About Market Risk18
Item 4Controls and Procedures18
PART IIOTHER INFORMATION
Item 1Legal Proceedings19
Item 1ARisk Factors19
Item 2Unregistered Sales of Equity Securities and Use of Proceeds19
Item 3Defaults Upon Senior Securities19
Item 4Mine Safety Disclosures19
Item 5Other Information19
Item 6Exhibits20
Signatures21
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.